Supplemental Materials for JAAD Publication JAAD-D-22-02295, A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Ivarmacitinib (SHR0302) in Adult Patients with Moderate to Severe Alopecia Areata
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/9xdmn8wc5f
下载链接
链接失效反馈官方服务：
资源简介：
These are supplemental data sets to the JAAD publication entitled "A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Ivarmacitinib (SHR0302) in Adult Patients with Moderate to Severe Alopecia Areata".
提供机构：
Xiaoyu Gu
